D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 27,159 373 World Ranking 6500 National Ranking 124

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Endocrinology

His primary scientific interests are in Internal medicine, Endocrinology, Neuropeptide Y receptor, Alcohol dependence and Central nervous system. His work deals with themes such as Habituation and Peptide, which intersect with Internal medicine. His Endocrinology study integrates concerns from other disciplines, such as Ethanol and Agonist.

His Neuropeptide Y receptor study incorporates themes from Endogeny, Corticosterone and Anxiolytic. His Alcohol dependence research is multidisciplinary, incorporating elements of Acamprosate, Naltrexone and Psychiatry, Alcohol abuse. His biological study spans a wide range of topics, including Cerebral cortex, Dopamine and Cortex.

His most cited work include:

  • Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides (526 citations)
  • Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides (526 citations)
  • The NPY system in stress, anxiety and depression. (477 citations)

What are the main themes of his work throughout his whole career to date?

Markus Heilig mostly deals with Internal medicine, Endocrinology, Pharmacology, Alcohol dependence and Receptor. His Internal medicine course of study focuses on Alcohol and Anesthesia. The various areas that Markus Heilig examines in his Endocrinology study include Neuropeptide, Neuropeptide Y receptor and Antagonist.

Within one scientific family, Markus Heilig focuses on topics pertaining to Nucleus accumbens under Pharmacology, and may sometimes address concerns connected to Ventral tegmental area. His studies deal with areas such as Genetics, Psychiatry, Alcohol abuse, Anxiety and Clinical psychology as well as Alcohol dependence. His study in Addiction and Substance abuse are all subfields of Psychiatry.

He most often published in these fields:

  • Internal medicine (45.52%)
  • Endocrinology (43.22%)
  • Pharmacology (21.48%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (45.52%)
  • Endocrinology (43.22%)
  • Alcohol (13.81%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Endocrinology, Alcohol, Alcohol use disorder and Pharmacology. Markus Heilig has researched Internal medicine in several fields, including Single-nucleotide polymorphism, Genetic variation and Depression. Markus Heilig does research in Endocrinology, focusing on Amygdala specifically.

His Alcohol research incorporates themes from Psychiatry, Drug, Ghrelin and Opioid. His research integrates issues of Nucleus accumbens and Inverse agonist in his study of Pharmacology. His work carried out in the field of Receptor brings together such families of science as Hormone and Animal studies.

Between 2017 and 2021, his most popular works were:

  • A molecular mechanism for choosing alcohol over an alternative reward (89 citations)
  • Alcohol use disorders (71 citations)
  • Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial (44 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Psychiatry

His scientific interests lie mostly in Pharmacology, Alcohol, Ghrelin, Prefrontal cortex and Internal medicine. His Pharmacology research includes elements of Cannabinoid, Fear conditioning, Endocannabinoid system and Anxiogenic. His study in Alcohol is interdisciplinary in nature, drawing from both Psychosocial, Global health, MEDLINE and Mass screening.

His research investigates the connection between Ghrelin and topics such as Alcohol use disorder that intersect with issues in Substance abuse, Clinical psychology, Neuroimaging, Neural correlates of consciousness and Functional magnetic resonance imaging. The Prefrontal cortex study combines topics in areas such as Somatosensory system, Superior temporal gyrus, Sensory system and Supramarginal gyrus. Internal medicine connects with themes related to Endocrinology in his study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

Claes Wahlestedt;Emilio Merlo Pich;George F. Koob;Frances Yee.
Science (1993)

702 Citations

The NPY system in stress, anxiety and depression.

Markus Heilig.
Neuropeptides (2004)

686 Citations

A key role for corticotropin-releasing factor in alcohol dependence

Markus Heilig;George F. Koob.
Trends in Neurosciences (2007)

565 Citations

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.

Johan Kakko;Kerstin Dybrandt Svanborg;Mary Jeanne Kreek;Markus Heilig.
The Lancet (2003)

515 Citations

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

Andrew Holmes;Markus Heilig;Nadia M.J. Rupniak;Thomas Steckler.
Trends in Pharmacological Sciences (2003)

492 Citations

Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.

Markus Heilig;Sarah McLeod;Michelle Brot;Steven C. Heinrichs.
Neuropsychopharmacology (1993)

440 Citations

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models.

Markus Heilig;Bo Söderpalm;Jörgen A. Engel;Erik Widerlöv.
Psychopharmacology (1989)

436 Citations

Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms

Markus Heilig;Mark Egli.
Pharmacology & Therapeutics (2006)

434 Citations

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration.

Markus Heilig;George F. Koob;Rolf Ekman;Karen T. Britton.
Trends in Neurosciences (1994)

413 Citations

Acute withdrawal, protracted abstinence and negative affect in alcoholism: Are they linked?

Markus Heilig;Mark Egli;John C. Crabbe;Howard C. Becker.
Addiction Biology (2010)

406 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Markus Heilig

George F. Koob

George F. Koob

National Institute on Drug Abuse

Publications: 182

Rainer Spanagel

Rainer Spanagel

Heidelberg University

Publications: 83

Marisa Roberto

Marisa Roberto

Scripps Research Institute

Publications: 70

Andrew J. Lawrence

Andrew J. Lawrence

Florey Institute of Neuroscience and Mental Health

Publications: 69

Herbert Herzog

Herbert Herzog

Garvan Institute of Medical Research

Publications: 65

Lara A. Ray

Lara A. Ray

University of California, Los Angeles

Publications: 61

Andrew Holmes

Andrew Holmes

National Institutes of Health

Publications: 56

Mary Jeanne Kreek

Mary Jeanne Kreek

Rockefeller University

Publications: 56

Falk Kiefer

Falk Kiefer

Heidelberg University

Publications: 53

John C. Crabbe

John C. Crabbe

Oregon Health & Science University

Publications: 43

David Goldman

David Goldman

National Institutes of Health

Publications: 42

Rajita Sinha

Rajita Sinha

Yale University

Publications: 42

Yavin Shaham

Yavin Shaham

National Institute on Drug Abuse

Publications: 40

Henry R. Kranzler

Henry R. Kranzler

University of Pennsylvania

Publications: 39

Sarah F. Leibowitz

Sarah F. Leibowitz

Rockefeller University

Publications: 39

Robert M. Swift

Robert M. Swift

Brown University

Publications: 39

Trending Scientists

Sylvia Ratnasamy

Sylvia Ratnasamy

University of California, Berkeley

Chunhua Liu

Chunhua Liu

City University of Hong Kong

Carl J. Carrano

Carl J. Carrano

San Diego State University

John A. Kilner

John A. Kilner

Imperial College London

Vincent B. C. Tan

Vincent B. C. Tan

National University of Singapore

Raimundo Real

Raimundo Real

University of Malaga

Paul R. Armsworth

Paul R. Armsworth

University of Tennessee at Knoxville

Sven Diederichs

Sven Diederichs

German Cancer Research Center

Fengxia Qi

Fengxia Qi

University of Oklahoma Health Sciences Center

Robert W. Chesnut

Robert W. Chesnut

Johns Hopkins University

Wei Qin

Wei Qin

Xidian University

John-Dylan Haynes

John-Dylan Haynes

Charité - University Medicine Berlin

Martine Cador

Martine Cador

University of Bordeaux

Andrew R. Mayer

Andrew R. Mayer

Mind Research Network

Joaquín Sastre

Joaquín Sastre

Instituto de Salud Carlos III

R. Reed Hunt

R. Reed Hunt

University of Mississippi

Something went wrong. Please try again later.